Details Standalone financial statements for the period ended 31 December 2020Standalone Financial StatementsBy adminMarch 2, 2021
Details Consolidated financial statements for the period ended 31 December 2020Consolidated Financial Statements resultsBy adminMarch 2, 2021
Disclosure to EGX on GlaxoSmithKline S.A.E response to Rameda’s acquisition request Regulatory DisclosuresBy adminFebruary 9, 2021
Disclosure to EGX on Rameda expressing interest in the acquisition of GlaxoSmithKline S.A.E Regulatory DisclosuresBy adminFebruary 2, 2021
